JP2002504083A - ヒアルロン酸および増殖因子による骨の増殖を促進する方法 - Google Patents
ヒアルロン酸および増殖因子による骨の増殖を促進する方法Info
- Publication number
- JP2002504083A JP2002504083A JP53207097A JP53207097A JP2002504083A JP 2002504083 A JP2002504083 A JP 2002504083A JP 53207097 A JP53207097 A JP 53207097A JP 53207097 A JP53207097 A JP 53207097A JP 2002504083 A JP2002504083 A JP 2002504083A
- Authority
- JP
- Japan
- Prior art keywords
- bone
- bfgf
- composition
- growth
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.ヒアルロン酸および増殖因子を含む骨増殖促進組成物であって、骨の増殖を 促進するのに充分な期間、骨の増殖が望まれる部位に維持されるために充分な 粘度と生分解性を有している前記組成物。 2.ヒアルロン酸が架橋されていない、請求項1に記載の組成物。 3.組成物がヒアルロン酸を溶液中に0.1〜4重量%で含む、請求項1に記載の 組成物。 4.増殖因子がbFGFを含む、請求項1に記載の組成物。 5.組成物中にbFGFが約10-6〜100mg/mlで存在している、請求項4に記載の組成 物。 6.骨の増殖が望まれる部位において骨の増殖を促進する方法であって、ヒアル ロン酸および増殖因子を含む組成物を前記部位に適用するステップを含み、前 記組成物が骨の増殖を促進するに充分な期間前記部位に維持されるために充分 な粘度と生分解性を有する、骨の増殖を促進する方法。 7.ヒアルロン酸が架橋されていない、請求項6に記載の方法。 8.組成物中のヒアルロン酸が組成物の約0.1〜4重量%を構成する、請求項6 に記載の方法。 9.増殖因子がbFGFを含む、請求項6に記載の方法。 10.組成物中にbFGFが約10-6〜100mg/mlで存在する、請求項9に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61169096A | 1996-03-05 | 1996-03-05 | |
US08/611,690 | 1996-03-05 | ||
PCT/US1997/004810 WO1997032591A1 (en) | 1996-03-05 | 1997-03-05 | Method of promoting bone growth with hyaluronic acid and growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002504083A true JP2002504083A (ja) | 2002-02-05 |
Family
ID=24450043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53207097A Pending JP2002504083A (ja) | 1996-03-05 | 1997-03-05 | ヒアルロン酸および増殖因子による骨の増殖を促進する方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0910389A4 (ja) |
JP (1) | JP2002504083A (ja) |
CN (1) | CN1149088C (ja) |
WO (1) | WO1997032591A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012116844A (ja) * | 2006-09-21 | 2012-06-21 | Toshiki Oguro | 硬組織再生促進剤 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221854B1 (en) * | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
EP2332564A1 (en) † | 1997-02-07 | 2011-06-15 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods thereof |
US20030147860A1 (en) | 2002-02-07 | 2003-08-07 | Marchosky J. Alexander | Compositions and methods for forming and strengthening bone |
IT1302534B1 (it) | 1998-12-21 | 2000-09-05 | Fidia Advanced Biopolymers Srl | Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per |
WO2001000792A1 (en) * | 1999-06-29 | 2001-01-04 | Marchosky J Alexander | Compositions and methods for forming and strengthening bone |
DE60012557T2 (de) * | 1999-10-15 | 2005-08-04 | Genetics Institute, LLC, Cambridge | Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine |
CN1198821C (zh) | 2000-04-19 | 2005-04-27 | 盐野义制药株式会社 | 磺酰胺衍生物的制备方法及其晶体 |
US6675048B2 (en) * | 2000-05-08 | 2004-01-06 | International Rehabilitative Sciences, Inc. | Electro-medical device for use with biologics |
US7747332B2 (en) | 2000-05-08 | 2010-06-29 | International Rehabilitative Sciences, Inc. | Electrical stimulation combined with a biologic to increase osteogenesis |
US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
EA008354B1 (ru) | 2002-05-17 | 2007-04-27 | Уайз | Инъецируемые твердые переносчики гиалуроновой кислоты для доставки остеогенных протеинов |
AU2013224728B2 (en) * | 2006-02-07 | 2016-10-20 | Takeda Pharmaceutical Company Limited | Stabilized Compositions of Proteins Having a Free Thiol Moiety |
DK1986612T3 (da) * | 2006-02-07 | 2012-10-29 | Shire Human Genetic Therapies | Stabiliserede proteinsammensætninger med en fri thioldel |
CN109172813B (zh) | 2009-07-28 | 2022-09-02 | 武田药品工业株式会社 | 用于治疗戈谢病的组合物和方法 |
CA2865614A1 (en) | 2012-03-02 | 2013-09-06 | Shire Human Genetic Therapies, Inc. | Compositions and methods for treating type iii gaucher disease |
DE102015009271A1 (de) * | 2015-07-19 | 2017-01-19 | Tracey Lennemann | Neue Verwendung von Hyaluronsäure |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5133755A (en) * | 1986-01-28 | 1992-07-28 | Thm Biomedical, Inc. | Method and apparatus for diodegradable, osteogenic, bone graft substitute device |
JPH02213A (ja) * | 1987-10-19 | 1990-01-05 | Taiho Yakuhin Kogyo Kk | 生理活性ペプチド持続製剤 |
US5470829A (en) * | 1988-11-17 | 1995-11-28 | Prisell; Per | Pharmaceutical preparation |
JPH04282322A (ja) * | 1991-03-08 | 1992-10-07 | Denki Kagaku Kogyo Kk | 生物活性ペプチド製剤 |
US5356629A (en) * | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
SE469653B (sv) * | 1992-01-13 | 1993-08-16 | Lucocer Ab | Poroest implantat |
WO1994001483A1 (en) * | 1992-07-02 | 1994-01-20 | Collagen Corporation | Biocompatible polymer conjugates |
-
1997
- 1997-03-05 WO PCT/US1997/004810 patent/WO1997032591A1/en active Application Filing
- 1997-03-05 EP EP97916976A patent/EP0910389A4/en not_active Withdrawn
- 1997-03-05 JP JP53207097A patent/JP2002504083A/ja active Pending
- 1997-03-05 CN CNB971928223A patent/CN1149088C/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012116844A (ja) * | 2006-09-21 | 2012-06-21 | Toshiki Oguro | 硬組織再生促進剤 |
Also Published As
Publication number | Publication date |
---|---|
WO1997032591A1 (en) | 1997-09-12 |
CN1149088C (zh) | 2004-05-12 |
EP0910389A1 (en) | 1999-04-28 |
EP0910389A4 (en) | 2001-09-19 |
CN1212628A (zh) | 1999-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5942499A (en) | Method of promoting bone growth with hyaluronic acid and growth factors | |
AU777328B2 (en) | Method of promoting bone growth with hyaluronic acid and growth factors | |
JP2002504083A (ja) | ヒアルロン酸および増殖因子による骨の増殖を促進する方法 | |
AU647905B2 (en) | Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention | |
DE69724257T2 (de) | Verwendung von oxydierter zellulose und ihrer komplexen zur behandlung von chronischen wunden | |
DE69814352T2 (de) | Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung | |
DE69838614T2 (de) | Zusammensetzungen von Carboxypolysaccharid-Polyetherkomplexen zur Verwendung zum Vermindern chirurgischer Verwachsungen | |
Subbiah et al. | Effects of controlled dual growth factor delivery on bone regeneration following composite bone-muscle injury | |
EP1220693B1 (en) | Formulations for delivery of osteogenic proteins | |
JP4879482B2 (ja) | 骨原性タンパク質を送達するための注入可能な固体ヒアルロン酸キャリア | |
JP2003512341A (ja) | 骨形成蛋白をデリバリーするためのヒアルロン酸の処方 | |
KR20110127746A (ko) | 주사용 바이오물질 | |
US20020183282A1 (en) | Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative | |
CA2246747C (en) | Method of promoting bone growth with hyaluronic acid and growth factors | |
US20110207666A1 (en) | Method of promoting bone growth with hyaluronic acid and growth factors | |
Goldstein et al. | Wound management of the airway mucosa: comparison with skin in a rabbit model | |
AU2005200146B2 (en) | Method of promoting bone growth with hyaluronic acid and growth factors | |
DE19513659A1 (de) | Polypeptid-enthaltende pharmazeutische Darreichungsformen in Form von Mikropartikeln und Verfahren zu deren Herstellung | |
JP4676581B2 (ja) | 肝実質細胞増殖因子含有医薬組成物 | |
AU2001254523B2 (en) | Treatment of damaged connective tissue | |
WO2001082951A1 (en) | Treatment of damaged connective tissue | |
KR20050019075A (ko) | 골형성 단백질의 전달을 위한 주사가능한 고체 히알루론산담체 | |
DD271268A5 (de) | Verfahren zur herstellung einer topisch anwendbaren pharmazeutischen zusammensetzung zur verhinderung von fibrinablagerungen oder verwachsungen | |
AU2001254523A1 (en) | Treatment of damaged connective tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071120 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080220 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080331 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080311 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080812 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081210 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090121 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090212 |
|
A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090312 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091021 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091102 |